These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22324424)

  • 1. An integrated approach to optimizing skin delivery of cosmetic and pharmaceutical actives.
    Abbott S
    Int J Cosmet Sci; 2012 Jun; 34(3):217-22. PubMed ID: 22324424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. smartPearls - Novel physically stable amorphous delivery system for poorly soluble dermal actives.
    Müller RH; Hespeler D; Jin N; Pyo SM
    Int J Pharm; 2019 Jan; 555():314-321. PubMed ID: 30439490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes: a novel topical delivery system for pharmaceutical and cosmetic applications.
    Weiner N; Lieb L; Niemiec S; Ramachandran C; Hu Z; Egbaria K
    J Drug Target; 1994; 2(5):405-10. PubMed ID: 7704485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced topical formulations (ATF).
    Hadgraft J; Lane ME
    Int J Pharm; 2016 Nov; 514(1):52-57. PubMed ID: 27260130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J; Hommoss A; Müller RH
    Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in cosmetics and skin care products.
    Draelos ZD
    Adv Dermatol; 1997; 12():3-17; discussion 18. PubMed ID: 8973733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetics, diet, and the future.
    Draelos ZD
    Dermatol Ther; 2012; 25(3):267-72. PubMed ID: 22913445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypodermal delivery of cosmetic actives for improved facial skin morphology and functionality.
    Bojanowski K
    Int J Cosmet Sci; 2013 Dec; 35(6):562-7. PubMed ID: 23802778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
    Shegokar R; Müller RH
    Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
    Müller RH; Petersen RD; Hommoss A; Pardeike J
    Adv Drug Deliv Rev; 2007 Jul; 59(6):522-30. PubMed ID: 17602783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational formulation design.
    Lane ME; Hadgraft J; Oliveira G; Vieira R; Mohammed D; Hirata K
    Int J Cosmet Sci; 2012 Dec; 34(6):496-501. PubMed ID: 22882873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosmetic features and applications of lipid nanoparticles (SLN, NLC).
    Souto EB; Müller RH
    Int J Cosmet Sci; 2008 Jun; 30(3):157-65. PubMed ID: 18452432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the human skin barrier--towards a better understanding of dermal absorption.
    Hansen S; Lehr CM; Schaefer UF
    Adv Drug Deliv Rev; 2013 Feb; 65(2):149-51. PubMed ID: 23266369
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antioxidant activity and in vivo efficacy of topical formulations containing vitamin C and its derivatives studied by non-invasive methods.
    Campos PM; Gonçalves GM; Gaspar LR
    Skin Res Technol; 2008 Aug; 14(3):376-80. PubMed ID: 19159387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.